Johnson & Johnson (JNJ)
258.37
+3.59
(+1.41%)
USD |
NYSE |
Oct 07, 16:00
258.40
+0.03
(+0.01%)
After-Hours: 19:07
Johnson & Johnson Market Cap : 622.21B for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 613.57B |
| October 05, 2026 | 609.11B |
| October 02, 2026 | 616.58B |
| October 01, 2026 | 622.91B |
| September 30, 2026 | 637.55B |
| September 29, 2026 | 644.37B |
| September 28, 2026 | 654.92B |
| September 25, 2026 | 653.16B |
| September 24, 2026 | 651.86B |
| September 23, 2026 | 648.22B |
| September 22, 2026 | 648.27B |
| September 21, 2026 | 648.95B |
| September 18, 2026 | 650.20B |
| September 17, 2026 | 650.75B |
| September 16, 2026 | 643.67B |
| September 15, 2026 | 643.48B |
| September 14, 2026 | 641.36B |
| September 11, 2026 | 639.58B |
| September 10, 2026 | 641.43B |
| September 09, 2026 | 643.19B |
| September 08, 2026 | 648.10B |
| September 04, 2026 | 662.82B |
| September 03, 2026 | 670.52B |
| September 02, 2026 | 662.77B |
| September 01, 2026 | 653.09B |
| Date | Value |
|---|---|
| August 31, 2026 | 640.23B |
| August 28, 2026 | 645.50B |
| August 27, 2026 | 640.03B |
| August 26, 2026 | 650.22B |
| August 25, 2026 | 657.78B |
| August 24, 2026 | 657.54B |
| August 21, 2026 | 650.80B |
| August 20, 2026 | 643.89B |
| August 19, 2026 | 658.43B |
| August 18, 2026 | 652.89B |
| August 17, 2026 | 631.85B |
| August 14, 2026 | 626.98B |
| August 13, 2026 | 631.15B |
| August 12, 2026 | 628.21B |
| August 11, 2026 | 625.66B |
| August 10, 2026 | 630.50B |
| August 07, 2026 | 624.31B |
| August 06, 2026 | 618.87B |
| August 05, 2026 | 620.34B |
| August 04, 2026 | 613.93B |
| August 03, 2026 | 612.68B |
| July 31, 2026 | 617.35B |
| July 30, 2026 | 616.07B |
| July 29, 2026 | 639.46B |
| July 28, 2026 | 642.35B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.119T |
| Merck & Co., Inc. | 352.37B |
| Pfizer Inc. | 159.49B |
| Bristol Myers Squibb Co. | 121.94B |
| Liquidia Corp. | 2.375B |
Market Cap Related Metrics
| PE Ratio | 29.95 |
| PS Ratio | 6.432 |
| Price to Book Value | 7.323 |
| Price to Free Cash Flow | 27.86 |
| Price | 258.37 |
| Earnings Yield | 3.34% |
| Operating PE Ratio | 23.83 |
| Normalized PE Ratio | 27.26 |